Page last updated: 2024-09-03

fosamprenavir and Hypercholesterolemia

fosamprenavir has been researched along with Hypercholesterolemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duong, T; Ene, L; Galli, L; Giaquinto, C; Goetghebuer, T; Judd, A; Noguera Julian, A; Pimenta, JM; Ramos Amador, JT; Thorne, C	1
Luque, I; Mallolas, J; Pérez-Elias, MJ; Rodríguez-Alcántara, F; Sánchez-Conde, M; Soriano, V	1

Trials

1 trial(s) available for fosamprenavir and Hypercholesterolemia

Article	Year
Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:1 Topics: Adult; Carbamates; CD4 Lymphocyte Count; Comorbidity; Drug Therapy, Combination; Female; Fever; Furans; Gastrointestinal Diseases; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Hypercholesterolemia; Hypertriglyceridemia; Male; Organophosphates; Ritonavir; RNA, Viral; Spain; Sulfonamides; Viral Load; Viremia	2009

Article

Year

Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program.

Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:1

Topics: Adult; Carbamates; CD4 Lymphocyte Count; Comorbidity; Drug Therapy, Combination; Female; Fever; Furans; Gastrointestinal Diseases; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Hypercholesterolemia; Hypertriglyceridemia; Male; Organophosphates; Ritonavir; RNA, Viral; Spain; Sulfonamides; Viral Load; Viremia

2009

Other Studies

1 other study(ies) available for fosamprenavir and Hypercholesterolemia

Article	Year
Post-licensing safety of fosamprenavir in HIV-infected children in Europe. Pharmacoepidemiology and drug safety, 2014, Volume: 23, Issue:3 Topics: Adolescent; Anti-HIV Agents; Carbamates; Child; Cohort Studies; Europe; Female; Follow-Up Studies; Furans; HIV Infections; Humans; Hypercholesterolemia; Male; Organophosphates; Pregnancy; Product Surveillance, Postmarketing; Retrospective Studies; Sulfonamides	2014

Article

Year

Post-licensing safety of fosamprenavir in HIV-infected children in Europe.

Pharmacoepidemiology and drug safety, 2014, Volume: 23, Issue:3

Topics: Adolescent; Anti-HIV Agents; Carbamates; Child; Cohort Studies; Europe; Female; Follow-Up Studies; Furans; HIV Infections; Humans; Hypercholesterolemia; Male; Organophosphates; Pregnancy; Product Surveillance, Postmarketing; Retrospective Studies; Sulfonamides

2014